Wang Yanchun, Wang Dongshu, Wang Xiaojing, Tao Haoxia, Feng Erling, Zhu Li, Pan Chao, Wang Bowen, Liu Chunjie, Liu Xiankai, Wang Hengliang
State Key Laboratory of Pathogens and Biosecurity, Beijing Institute of Biotechnology, Beijing, China.
Front Microbiol. 2019 Aug 27;10:1932. doi: 10.3389/fmicb.2019.01932. eCollection 2019.
Genome editing is an effective tool for the functional examination of bacterial genes and for live attenuated vaccine construction. Here, we report a method to edit the genomic DNA of and using the clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein (Cas)9 system. Using two prophages in as targets, large-fragment deletion mutants were achieved with rates of 100 or 20%. In , we successfully introduced precise point mutations into , with phenotypic assays showing that the resulting mutants lost hemolytic and phospholipase enzyme activities similar to , which is a natural mutant. Our study indicates that CRISPR/Cas9 is a powerful genetic tool for genome editing in the group, and can efficiently modify target genes without the need for residual foreign DNA such as antibiotic selection markers. This system could be developed for use in the generation of marker-free live anthrax vaccines or for safer construction of microbiological candidate-based recombinant .
基因组编辑是用于细菌基因功能检测和减毒活疫苗构建的有效工具。在此,我们报告一种使用成簇规律间隔短回文重复序列(CRISPR)/CRISPR相关蛋白(Cas)9系统编辑炭疽杆菌和蜡样芽胞杆菌基因组DNA的方法。以炭疽杆菌中的两种原噬菌体为靶点,获得了大片段缺失突变体,其发生率分别为100%或20%。在蜡样芽胞杆菌中,我们成功地将精确的点突变引入到plcR基因中,表型分析表明,所得突变体失去了溶血和磷脂酶活性,类似于自然的蜡样芽胞杆菌突变体。我们的研究表明,CRISPR/Cas9是用于芽孢杆菌属基因组编辑的强大遗传工具,并且无需抗生素选择标记等残留外源DNA就能有效修饰靶基因。该系统可用于开发无标记的活炭疽疫苗,或用于更安全地构建基于微生物候选物的重组体。